×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ABBOTT INDIA LTD. | NA | NA | NA | NA | 65,736 | 45.3 |
| AUROBINDO PHARMA LTD. | 29319.4 | 5591.3 | 28481.7 | 9.63 | 64989 | 19.2 |
| Alkem Laboratories Limited | 24887.5 | 6561.6 | 23721.7 | 52.04 | 64487 | 28.4 |
Abbott India Ltd., with Security Code 500488, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,326.5 | 1,343.1 | 1,479.0 | 1,494.1 | 1,437.1 | 1,438.6 | 1,557.6 | 1,632.7 | 1,614.3 | 1,604.6 |
| Expenses | 1,010.0 | 1,063.0 | 1,124.0 | 1,113.3 | 1,049.5 | 1,109.1 | 1,166.6 | 1,193.7 | 1,178.2 | 1,176.1 |
| Operating Profit | 316.5 | 280.1 | 355.0 | 380.9 | 387.7 | 329.5 | 391.0 | 439.0 | 436.1 | 428.5 |
| OPM % | 23.86% | 20.86% | 24% | 25.49% | 26.98% | 22.91% | 25.1% | 26.89% | 27.01% | 26.71% |
| Other Income | 39.9 | 49.6 | 56.0 | 55.5 | 55.6 | 81.2 | 67.3 | 60.5 | 71.8 | 76.0 |
| Interest | 3.8 | 4.0 | 3.3 | 3.1 | 3.2 | 2.8 | 2.8 | 2.5 | 2.3 | 3.9 |
| Depreciation | 17.8 | 17.3 | 17.2 | 17.8 | 18.0 | 18.2 | 18.4 | 17.5 | 18.0 | 17.9 |
| Profit before tax | 334.8 | 308.4 | 390.5 | 415.4 | 422.2 | 389.7 | 437.2 | 479.4 | 487.6 | 482.7 |
| Tax % | -26.3% | -25% | -25.7% | -24.7% | -26.3% | -26.3% | -25% | -25.2% | -26% | -23.9% |
| Net Profit | 246.8 | 231.4 | 290.2 | 312.9 | 311.0 | 287.1 | 328.0 | 358.6 | 360.8 | 367.0 |
| EPS in Rs | 116.16 | 108.9 | 136.58 | 147.27 | 146.34 | 135.09 | 154.36 | 168.76 | 169.78 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 19% |
| 3 Years: | 21% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | 20% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|